Copy


NIH INFORMED

Issue No. 12, 2021
Insights from NIH notices and reviewer comments, so you can focus.
 
DECEMBER TIP
 

My ESI status runs out in late January, even after applying for any eligible exensions (e.g., pandemic-related research interruptions; childbirth). So I’m out of luck now trying to apply for an R01 under ESI status, correct?

Not necessarily.

I had a grantee a few months ago whose ESI status was expiring in late September 2021. His PO told him that if he uploaded his new R01 (Oct 5 deadline) before that late September ESI expiration date, that his application would be reviewed as ESI. I had never heard this before, and I encourage you to check with your PO about your specific set of circumstances. In addition, remember that if you submit an A0 (new submission) just before your ESI status expires, The A1 (resubmission) would be reviewed as ESI also, as long as you submit it within 13 months of the A0.

DECEMBER NEWS
  1. Encouragement of applications supporting individuals from underrepresented ethnic and racial groups and individuals with disabilities
  2. Administrative supplements for research on health inequities among women who are underrepresented, understudied, and underreported
  3. NIH UNITE listening sessions on racial and ethnic equity
  4. The latest roundup of some NIH-sponsored COVID-19 research
1. NIH encourages applications supporting individuals from underrepresented ethnic and racial groups and individuals with disabilities
NIH issued a reminder to the research community that it encourages applications from individuals from underrepresented ethnic and racial groups and individuals with disabilities. The original Notice of Interest in Diversity contains a diversity statement and implementation timeline, as well as guidance and links regarding underrepresented populations. 
2. Administrative supplements for research on health inequities among women who are underrepresented, understudied, and underreported
The NIH Office of Research on Women’s Health (ORWH) announces administrative supplements for research on health inequities among women in the US who are underrepresented, understudied, and underreported (U3) in biomedical research. The proposed research must address at least one objective from strategic goals 1, 2, or 3 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research, Advancing Science for the Health of Women. The NIH Notice contains full details, including eligibility, a link to the Trans-NIH Strategic Plan, and specific areas of research interest.
3. NIH UNITE listening sessions on racial and ethnic equity
NIH is holding a series of UNITE Listening Sessions inviting stakeholders to discuss racial and ethnic equity. UNITE was established to identify and address structural racism within NIH-supported entities and the greater scientific community. Complete details regarding the initiative as well as listening sessions dates and times are  available in the NOT.
4. The latest roundup of some NIH-sponsored COVID-19 research
Over the past year, the NIH has maintained the scientific community abreast of COVID-19 developments via a website with news releases regarding research findings and clinical trials attempting to address the pandemic. As the situation evolved, so has NIH’s information. 
 
The site now lists NIH’s strategic priorities for COVID-19 research, as well as a PDF of the 2021 NIH-wide COVID-19 Strategic Plan. Additionally, there is a page outlining COVID-19 research initiatives across its centers and institutes. 
 
We’ll continue sharing COVID-19 related headlines, but we encourage you to visit the resources above. 

Here are some other COVID-19 related headlines:

Exciting News!
Our new course library platform is now live!

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for current NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She currently supports 2 of the top 3-ranked hospitals; 4 of the top 6 cancer hospitals; and 3 of the top 6-ranked medical schools for research in the country. She has helped clients land over $400 million in federal funding. Meg Bouvier Medical Writing, LLC is a woman-owned, small business.

Was this newsletter forwarded to you?

 
When you join my mailing list I'll pass along important NIH changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.  
Website
LinkedIn
Twitter
Copyright © 2022 Meg Bouvier Medical Writing, LLC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp